apperley j
Imperial College London
H-index: 127
Europe-United Kingdom
Top articles of apperley j
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Treatment-free remission in CML patients with additional chromosome abnormalities in the Philadelphia-positive clone or variant Philadelphia translocations. | American Journal of Hematology | Simone Claudiani Lynette Chee Fiona Fernando Loretta Brown Udayakumar M Achandira | 2024/3/4 |
Project Confirm: Accelerated Drug Approvals for CML—Response | Clinical Cancer Research | Kendra L Sweet Jorge E Cortes Jane F Apperley Mel Mann Michael J Mauro | 2024/1/5 |
Long-term outcomes after upfront second-generation tyrosine kinase inhibitors for chronic myeloid leukemia: managing intolerance and resistance | Leukemia | Simone Claudiani Farhan Chughtai Afzal Khan Chloe Hayden Fiona Fernando | 2024/2/29 |
Graft-versus-host disease prophylaxis with post-transplantation cyclophosphamide in chronic myeloid leukemia patients undergoing allogeneic hematopoietic cell transplantation … | Transplantation and Cellular Therapy | Guillermo Ortí Luuk Gras Linda Koster Aleksander Kulagin Jenny Byrne | 2024/1/1 |
Chronic myeloid leukemia diagnosed in pregnancy: management and outcome of 87 patients reported to the European LeukemiaNet international registry | Leukemia | Ekaterina Chelysheva Jane Apperley Anna Turkina Mohamed A Yassin Delphine Rea | 2024/2/23 |
Targeting lysine demethylase 5 (KDM5) in mantle cell lymphoma | Blood Cancer Journal | Danmei Xu Findlay Bewicke-Copley Karina Close Jessica Okosun Robert Peter Gale | 2024/2/13 |
Effect of tyrosine kinase inhibitors on male fertility in patients with chronic phase chronic myeloid leukemia | Leukemia & Lymphoma | George Nesr Simone Claudiani Dragana Milojkovic Andrew Innes Fiona Fernando | 2024/4/23 |
Richard Szydlo, July 1 1959–December 18 2023 | Bone Marrow Transplantation | Jane F Apperley | 2024/2/9 |
The EBMT: History, Present, and Future | Anna Sureda Nicolaus Kröger Jane Apperley Alois Gratwohl | 2024/4/11 | |
Aleukemic Chronic Myeloid Leukemia Without Neutrophilia and Thrombocytosis: a Report From the BCR:: ABL1 Pathology Group | Modern Pathology | Daniel Rivera Wei Cui Juehua Gao Deniz Peker Qian-Yun Zhang | 2024/2/1 |
Mismatched related donor allogeneic haematopoietic cell transplantation compared to other donor types for Ph+ chronic myeloid leukaemia: A retrospective analysis from the … | British Journal of Haematology | Francesco Onida Luuk Gras Junran Ge Linda Koster Rose‐Marie Hamladji | 2024/4/5 |
Dose modification dynamics of ponatinib in patients with chronic-phase chronic myeloid leukemia (CP-CML) from the PACE and optic trials | Leukemia | Elias Jabbour Jane Apperley Jorge Cortes Delphine Rea Michael Deininger | 2024/1/29 |
European LeukemiaNet laboratory recommendations for the diagnosis and management of chronic myeloid leukemia | Nicholas CP Cross Thomas Ernst Susan Branford Jean-Michel Cayuela Michael Deininger | 2023/11 | |
Are syngeneic donors a viable donor option in allogeneic haematopoietic cell transplantation for MDS? A brief report on behalf of the Chronic Malignancies Working Party of the … | Marie Robin Luuk Gras Linda Koster Riccardo Saccardi Jürgen Finke | 2023/8 | |
Porównanie asciminibu z bosutynibem w leczeniu pacjentów z przewlekłą białaczką szpikową w fazie przewlekłej leczonych wcześniej co najmniej dwoma inhibitorami kinazy … | Hematologia-Edukacja | Andreas Hochhaus Delphine Réa Carla Boquimpani Yosuke Minami Jorge E Cortes | 2023 |
CML-313 Post Hoc Analysis of Patient Responses by T315I Mutation Status From the 3-Year Update of the OPTIC Trial: A Dose-Optimization Study of 3 Starting Doses of Ponatinib | Clinical Lymphoma Myeloma and Leukemia | Jorge Cortes Michael Deininger Elza Lomaia Beatriz Moiraghi Maria Undurraga Sutton | 2023/9/1 |
COVID-19 vaccine boosted immunity against Omicron in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors | Leukemia | Dragana Milojkovic Catherine J Reynolds Diana Mūnoz Sandoval Franziska P Pieper Siyi Liu | 2023/1 |
FISH-negative BCR::ABL1-positive e19a2 chronic myeloid leukaemia: the most cryptic of insertions | BMC Medical Genomics | Philippa C May Alistair G Reid Mark E Robinson Jamshid S Khorashad Dragana Milojkovic | 2023/7/26 |
CML-319 Molecular Response of≤ 10% BCR:: ABL1IS Is Predictive of Positive Outcomes in Patients With Treatment-Resistant Chronic-Phase Chronic Myeloid Leukemia (CP-CML) Treated … | Clinical Lymphoma Myeloma and Leukemia | Jane Apperley Jorge Cortes Elias Jabbour Andreas Hochhaus Timothy Hughes | 2023/9/1 |
Allogeneic hematopoietic cell transplantation in patients with chronic phase chronic myeloid leukemia in the era of third generation tyrosine kinase inhibitors: A retrospective … | Bone Marrow Transplantation | Mitja Nabergoj Katya Mauff Dietrich Beelen Arnold Ganser Nicolaus Kröger | 2022/7 |
